Multifaceted plasminogen.

Arch Oral Biol

Department of Oral Biology, Faculty of Odontology, Malmö University College, S-205 06 Malmö, Sweden. Electronic address:

Published: February 2017

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.archoralbio.2016.12.004DOI Listing

Publication Analysis

Top Keywords

multifaceted plasminogen
4
multifaceted
1

Similar Publications

Pulmonary embolism (PE) is the third most frequent cause of acute cardiovascular presentation after myocardial infarction and stroke. The treatment approach for PE consists of hemodynamic and respiratory support, anticoagulation, reperfusion treatment, and vena cava filters. Reperfusion treatment consists of systemic thrombolysis (recombinant tissue-type plasminogen activator, streptokinase, and urokinase); percutaneous catheter-directed therapy (CDT); and surgical embolectomy.

View Article and Find Full Text PDF

Plasminogen activator inhibitor-1 (PAI-1) is a vital regulator of the fibrinolytic mechanism and has been intricately involved in various physiological and clinical processes, including cancer, thrombosis, and wound healing. The PAI-1 signaling pathway is multifaceted, encompassing numerous signaling molecules and nodes. Recent studies have revealed a novel contribution of PAI-1 during cellular senescence.

View Article and Find Full Text PDF

From blood to brain: Exploring the role of fibrinogen in the pathophysiology of depression and other neurological disorders.

Int Immunopharmacol

December 2024

Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500046, Telangana, India. Electronic address:

Article Synopsis
  • * The connection between fibrinogen and neurotransmitters like serotonin suggests that fibrinogen could play a role in mood regulation, with its interaction with astrocytes potentially leading to nerve fiber damage, contributing to depressive symptoms.
  • * There's potential for therapeutic strategies targeting fibrinogen, such as adjusting PAI-1 activity or blocking its interaction with brain cells, but more research is needed to understand the complexities of fibrinogen's role in mood disorders
View Article and Find Full Text PDF

Pulmonary fibrosis, a debilitating lung disorder characterised by excessive fibrous tissue accumulation in lung parenchyma, compromises respiratory function leading to a life-threatening respiratory failure. While its origins are multifaceted and poorly understood, the urokinase system, including urokinase-type plasminogen activator (uPA) and its receptor (uPAR), plays a significant role in regulating fibrotic response, extracellular matrix remodelling, and tissue repair. Mesenchymal stem/stromal cells (MSCs) hold promise in regenerative medicine for treating pulmonary fibrosis.

View Article and Find Full Text PDF

The urokinase-type plasminogen activator receptor (uPAR) is a unique protease binding receptor, now recognized as a key regulator of inflammation. Initially, uPA/uPAR was considered thrombolytic (clot-dissolving); however, recent studies have demonstrated its predominant immunomodulatory functions in inflammation and cancer. The uPA/uPAR complex has a multifaceted central role in both normal physiological and also pathological responses.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!